Preclinical studies should also explore the role of triglycerides in angiogenesis to distinguish the triglyceride‐dependent and ‐independent effects of ApoC3 in inflammatory and hypoxic PAD models. This evidence concerns the gene APOC3 and peripheral arterial disease.